Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
Nefrologia ; 36(3): 255-67, 2016.
Artículo en Inglés, Español | MEDLINE | ID: mdl-27133898

RESUMEN

BACKGROUND AND OBJECTIVES: The relationship between mineral metabolism disorders, bone fractures and vascular calcifications in kidney transplant recipients has not been established. METHOD: We performed a cross-sectional study in 727 stable recipients from 28 Spanish transplant clinics. Mineral metabolism parameters, the semi-quantification of vertebral fractures and abdominal aortic calcifications were determined centrally. RESULTS: Vitamin D deficiency (25OHD3<15ng/ml) was more common in female recipients at CKD-T stages I-III (29.6% vs 44.4%; p=0.003). The inverse and significant correlation between 25OHD3 and PTH was gender-specific and women exhibited a steeper slope than men (p=0.01). Vertebral fractures (VFx) with deformity grade ≥2 were observed in 15% of recipients. Factors related to VFx differed by gender; in males, age (OR 1.04; 95% CI 1.01-1.06) and CsA treatment (OR: 3.2; 95% CI: 1.6-6.3); in females, age (OR 1.07; 95% CI: 1.03-1.12) and PTH levels (OR per 100pg/ml increase: 1.27; 95% CI: 1.043-1.542). Abdominal aortic calcifications were common (67.2%) and related to classical risk factors but not to mineral metabolism parameters. CONCLUSIONS: Vitamin D deficiency is more common among female kidney transplant recipients at earlier CKD-T stages, and it contributes to secondary hyperparathyroidism. Prevalent vertebral fractures are only related to high serum PTH levels in female recipients.


Asunto(s)
Enfermedades de la Aorta/metabolismo , Calcinosis/metabolismo , Trasplante de Riñón , Minerales/metabolismo , Complicaciones Posoperatorias/metabolismo , Factores Sexuales , Fracturas de la Columna Vertebral/metabolismo , Anciano , Albuminuria/etiología , Aorta Abdominal , Enfermedades de la Aorta/etiología , Calcinosis/etiología , Estudios Transversales , Ciclosporina/efectos adversos , Femenino , Humanos , Hiperparatiroidismo Secundario/etiología , Hiperparatiroidismo Secundario/metabolismo , Inmunosupresores/efectos adversos , Masculino , Persona de Mediana Edad , Hormona Paratiroidea/sangre , Factores de Riesgo , Fracturas de la Columna Vertebral/etiología , Tacrolimus/efectos adversos , Deficiencia de Vitamina D/complicaciones
2.
Endocrine ; 49(1): 267-73, 2015 May.
Artículo en Inglés | MEDLINE | ID: mdl-25154517

RESUMEN

Little is known about the effects of the administration of cinacalcet in dialytic patients who are scheduled for kidney transplantation, and in particular about the changes in FGF23 and other mineral metabolism parameters after surgery compared with recipients not on cinacalcet at kidney transplantation. We performed a prospective observational cohort study with recruitment of consecutive kidney transplant recipients at our institution. Patients were classified according to whether they were under treatment with cinacalcet before transplantation. Bone mineral metabolism parameters, including C-terminal FGF23, were measured at baseline, on day 15, and at 1, 3, and 6 months after transplantation. In previously cinacalcet-treated patients, cinacalcet therapy was discontinued on the day of surgery and was not restarted after transplantation. A total of 48 kidney transplant recipients, 20 on cinacalcet at surgery and 28 cinacalcet non-treated patients, completed the follow-up. Serum phosphate declined significantly in the first 15 days after transplantation with no differences between the two groups, whereas cinacalcet-treated patients showed higher FGF23 levels, although not significant. After transplantation, PTH and serum calcium were significantly higher in cinacalcet-treated patients. We conclude that patients receiving cinacalcet on dialysis presented similar serum phosphate levels but higher PTH and serum calcium levels during the initial six months after kidney transplantation than cinacalcet non-treated patients. The group previously treated with cinacalcet before transplantation showed higher FGF23 levels without significant differences, so further studies should investigate its relevance in the management of these patients.


Asunto(s)
Huesos/metabolismo , Calcimiméticos/farmacología , Calcio/sangre , Cinacalcet/farmacología , Factores de Crecimiento de Fibroblastos/sangre , Hipercalcemia/sangre , Hipofosfatemia/sangre , Trasplante de Riñón , Fosfatos/sangre , Adulto , Anciano , Calcimiméticos/administración & dosificación , Cinacalcet/administración & dosificación , Femenino , Factor-23 de Crecimiento de Fibroblastos , Humanos , Masculino , Persona de Mediana Edad , Estudios Prospectivos
3.
Clin Nucl Med ; 38(11): 878-81, 2013 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-24089071

RESUMEN

PURPOSE: The aim of the study was to determine if pinhole collimator-acquired images can improve the detection of hyperfunctioning parathyroid glands in patients with secondary hyperparathyroidism. METHODS: Forty-two patients being treated with cinacalcet for secondary hyperparathyroidism were studied prospectively. Patients were divided into 2 groups according to their levels of parathyroid hormone (PTH), the hormone that defines response to treatment: "responders" (PTH <300 pg/mL) and "nonresponders" (PTH ≥ 300 pg/mL). Double-phase scintigraphy using 888 MBq of (99m)Tc-MIBI was used to acquire early and late parallel-hole and pinhole collimator images. Neck ultrasonography was performed on all patients to identify intrathyroid nodules. All focal uptake in any of the acquired scintigraphic images was considered positive. RESULTS: The responder group included 24 patients, whereas 18 patients were considered as nonresponders. At least 1 parathyroid gland with (99m)Tc-MIBI uptake was detected in 33 of 42 patients, with a total of 50 parathyroid glands located. We found significant differences between the detection rates of late pinhole collimator and the late parallel-hole images (74% vs 48%, P = 0.0036). This detection rate was highest with late parallel-hole images in the nonresponder group (89%). CONCLUSIONS: The late pinhole collimator acquisition showed the highest detection rate of hyperfunctioning parathyroid glands using (99m)Tc-MIBI scintigraphy in secondary hyperparathyroidism patients treated with cinacalcet.


Asunto(s)
Hiperparatiroidismo Secundario/diagnóstico por imagen , Cintigrafía/instrumentación , Tecnecio Tc 99m Sestamibi , Femenino , Humanos , Masculino , Persona de Mediana Edad , Glándulas Paratiroides/diagnóstico por imagen , Ultrasonografía
4.
Transplantation ; 94(8): 830-6, 2012 Oct 27.
Artículo en Inglés | MEDLINE | ID: mdl-23018879

RESUMEN

BACKGROUND: Levels of fibroblast growth factor (FGF)-23, a phosphaturic hormone, increase from the early stages of CKD and are dramatically elevated in dialysis patients. Excessive FGF-23 may be involved in the hypophosphatemia and inappropriately low calcitriol levels observed after kidney transplantation (KT).This prospective observational cohort study was carried out to determine whether there are any differences in the changes in FGF-23 levels after surgery in KT recipients according to whether they were or not on dialysis before transplantation and to assess the influence of FGF-23 in the development of posttransplantation hypophosphatemia. METHODS: Consecutive KT recipients at the Hospital Clinic of Barcelona were recruited. Patients developing delayed graft function were excluded. Mineral metabolism parameters, including C-terminal fragment of FGF-23, intact parathyroid hormone, and 1,25(OH)(2)D(3), were measured in 72 KT recipients (58 on dialysis before transplantation and 14 preemptive transplant recipients) at baseline, on day 15, and at 1, 3, and 6 months after transplantation. No patients received treatment with calcimimetics, bisphosphonates, vitamin D, or phosphate supplementation during the follow-up. RESULTS: FGF-23 decreased significantly in the first month after transplantation. Baseline and FGF-23 levels within the first posttransplantation month were lower in preemptive transplant recipients than in patients on dialysis at transplantation. Serum phosphate levels were lower in dialysis patients until the third month after transplantation. Pretransplantation FGF-23 was the main predictor of posttransplantation phosphate blood levels. CONCLUSIONS: FGF-23 levels and the risk of developing posttransplantation hypophosphatemia were lower in preemptive kidney transplant recipients than in patients on dialysis before transplantation.


Asunto(s)
Factores de Crecimiento de Fibroblastos/sangre , Hipofosfatemia/etiología , Trasplante de Riñón/efectos adversos , Adulto , Anciano , Calcifediol/sangre , Calcitriol/sangre , Calcio/sangre , Estudios de Cohortes , Creatinina/sangre , Femenino , Factor-23 de Crecimiento de Fibroblastos , Humanos , Masculino , Persona de Mediana Edad , Hormona Paratiroidea/sangre , Estudios Prospectivos
5.
Nefrología (Madr.) ; 36(3): 255-267, mayo-jun. 2016. ilus, graf, tab
Artículo en Inglés | IBECS (España) | ID: ibc-153210

RESUMEN

Antecedentes y objetivos: La relación entre las alteraciones del metabolismo mineral, las fracturas óseas y las calcificaciones vasculares en receptores de un trasplante renal no han sido establecidas. Método: Realizamos un estudio transversal en 727 receptores estables procedentes de 28 centros de trasplante españoles. Se determinaron de manera centralizada los parámetros del metabolismo mineral; también se centralizó la semicuantificación de las fracturas vertebrales y de las calcificaciones de la aorta abdominal. Resultados: La deficiencia de vitamina D (25OHD3 < 15ng/ml) fue más frecuente en mujeres y en los estadios CKD-T I-III (29,6 vs. 44,4%; p=0,003). La relación inversa y significativa observada entre los niveles de 25OHD3 y PTH fue modificada por el género de tal manera que la pendiente fue mayor en las mujeres que en los hombres (p=0,01). Un 15% de los receptores mostró alguna fractura vertebral (VFx) con un grado de deformidad ≥2. Los factores relacionados con la VFx diferían en función del género: en los hombres, la edad (OR: 1,04; IC 95%: 1,01-1,06) y el tratamiento con CsA (OR: 3,2; IC 95: 1,6-6,3); en las mujeres la edad (OR: 1,07; IC 95%: 1,03-1,12) y los niveles de PTH (OR per 100pg/ml increase: 1,27; IC 95%: 1,043-1,542). Las calcificaciones de la aorta abdominal fueron comunes (67,2%) y se relacionaron con los factores de riesgo clásicos, pero no con los parámetros del metabolismo mineral. Conclusiones: La deficiencia de vitamina D es más frecuente en las mujeres receptoras de un trasplante renal y en los estadios más tempranos de la CKD-T, y es un factor que contribuye al desarrollo de hiperparatiroidismo secundario. Las VFx prevalentes están relacionadas con unos niveles más elevados de PTH solamente en las mujeres (AU)


Background and objectives: The relationship between mineral metabolism disorders, bone fractures and vascular calcifications in kidney transplant recipients has not been established. Method: We performed a cross-sectional study in 727 stable recipients from 28 Spanish transplant clinics. Mineral metabolism parameters, the semi-quantification of vertebral fractures and abdominal aortic calcifications were determined centrally. Results: Vitamin D deficiency (25OHD3 < 15 ng/ml) was more common in female recipients at CKD-T stages I–III (29.6% vs 44.4%; p=0.003). The inverse and significant correlation between 25OHD3 and PTH was gender-specific and women exhibited a steeper slope than men (p=0.01). Vertebral fractures (VFx) with deformity grade ≥2 were observed in 15% of recipients. Factors related to VFx differed by gender; in males, age (OR 1.04; 95% CI 1.01-1.06) and CsA treatment (OR: 3.2; 95% CI: 1.6-6.3); in females, age (OR 1.07; 95% CI: 1.03-1.12) and PTH levels (OR per 100 pg/ml increase: 1.27; 95% CI: 1.043-1.542). Abdominal aortic calcifications were common (67.2%) and related to classical risk factors but not to mineral metabolism parameters. Conclusions: Vitamin D deficiency is more common among female kidney transplant recipients at earlier CKD-T stages, and it contributes to secondary hyperparathyroidism. Prevalent vertebral fractures are only related to high serum PTH levels in female recipients (AU)


Asunto(s)
Humanos , Enfermedades Metabólicas/epidemiología , Fracturas de la Columna Vertebral/epidemiología , Calcificación Vascular/epidemiología , Trasplante de Riñón/efectos adversos , Distribución por Sexo , Deficiencia de Vitamina D/epidemiología , Hiperparatiroidismo Secundario/epidemiología , Ciclosporina/uso terapéutico , Tacrolimus/uso terapéutico , Minerales en la Dieta/metabolismo
7.
J. bras. nefrol ; 36(4): 545-548, Oct-Dec/2014. tab, graf
Artículo en Portugués | LILACS | ID: lil-731147

RESUMEN

O fruto biri-biri pertence à família das Oxalidacae, espécie Averrhoa bilimbi. Este fruto tem um alto conteúdo de oxalato solúvel e é utilizado na culinária, na produção de picles, geleias, e como tratamento para algumas doenças como hipertensão, diabetes e hiperlipidemia. Assim como outros frutos ricos em oxalato, pode provocar lesão renal aguda. Relatamos o caso de um paciente de 50 anos, hipertenso, com função renal normal, que ingeriu uma grande quantidade de suco em jejum para tratamento de hipertensão. O paciente desenvolveu quadro de lesão renal aguda associado a dores lombares, soluços e diarreia. A lesão renal aguda era não oligúrica e teve uma evolução favorável em 10 dias sem necessidade de tratamento dialítico. A função renal retornou ao normal após esses 10 dias de seguimento.


Asunto(s)
Humanos , Biomarcadores de Tumor/análisis , Carcinoma Hepatocelular/química , Neoplasias Hepáticas/química , Apoptosis , Biomarcadores de Tumor/genética , Carcinógenos , Adhesión Celular , División Celular , Carcinoma Hepatocelular/irrigación sanguínea , Carcinoma Hepatocelular/genética , Carcinoma Hepatocelular/patología , Núcleo Celular/patología , Matriz Extracelular/metabolismo , Neoplasias Hepáticas/irrigación sanguínea , Neoplasias Hepáticas/genética , Neoplasias Hepáticas/patología , Neovascularización Patológica , Ploidias , Pronóstico , Proteoma/genética , Telomerasa/metabolismo
8.
J. bras. patol. med. lab ; 48(1): 29-31, fev. 2012. ilus
Artículo en Portugués | LILACS | ID: lil-617014

RESUMEN

Chryseobacterium indologenes é uma bactéria de baixa virulência, encontrada no meio ambiente, raramente associada às infecções não hospitalares. A maioria das infecções causadas por ela associa-se ao uso de dispositivos invasivos durante a permanência em hospital. O presente relato trata de paciente renal crônico, diabético, apresentando episódios de bacteriemia durante sessões de hemodiálise ambulatorial por meio de cateter permcath.


Chryseobacterium indologenes is a low-virulent bacterium found in the environment, which is rarely associated with non-nosocomial infections. Most infections caused by this pathogen are associated with the use of invasive devices in hospitalized patients. This study reports the case of a diabetic patient with chronic renal disease presenting episodes of bacteremia undergoing ambulatory hemodialysis with permcath catheter.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA